Literature DB >> 3042626

Treatment and prevention of pertussis by antimicrobial agents (Part II).

J E Hoppe1, A Haug.   

Abstract

Suitable antimicrobials given during the catarrhal stage of whooping cough can attenuate the course of the disease. The efficacy of antibiotics administered prophylactically during the incubation period remains controversial but appears to be beneficial. Currently, erythromycin given for two weeks is the antibiotic of choice for pertussis. No treatment failures were observed with erythromycin estolate. Erythromycin ethylsuccinate and stearate must be given at high dosages (50-60 mg/kg/day) in order to achieve sufficient concentrations in the respiratory secretions. With ampicillin and amoxicillin treatment failures have been observed. The role of josamycin and co-trimoxazole in pertussis remains open.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3042626     DOI: 10.1007/BF01644089

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  38 in total

1.  TREATMENT of whooping-cough with antibiotics; a report by the whooping-cough subcommittee of the Antibiotics Clinical Trials (non-tuberculous conditions) Committee of the Medical Research Council.

Authors: 
Journal:  Lancet       Date:  1953-06-06       Impact factor: 79.321

2.  Antimicrobial drugs in the treatment and prevention of pertussis.

Authors:  H Lambert
Journal:  J Antimicrob Chemother       Date:  1979-07       Impact factor: 5.790

3.  Effect of erythromycin and amoxycillin on Bordetella pertussis in the nasopharynx.

Authors:  B Trollfors
Journal:  Infection       Date:  1978       Impact factor: 3.553

4.  Antibiotic treatment of pertussis.

Authors:  J D Nelson
Journal:  Pediatrics       Date:  1969-10       Impact factor: 7.124

5.  Whooping cough--aspects of pathogenesis and treatment.

Authors:  B Trollfors
Journal:  Acta Otolaryngol Suppl       Date:  1984

6.  Antibiotic susceptibility testing of Bordetella pertussis.

Authors:  L H Field; C D Parker
Journal:  Am J Clin Pathol       Date:  1980-09       Impact factor: 2.493

7.  Nosocomial pertussis: a failure of erythromycin treatment and prophylaxis.

Authors:  N A Halsey; M A Welling; R M Lehman
Journal:  Am J Dis Child       Date:  1980-05

8.  [Cefotaxime and Gram-negative infections in children. Effectiveness and tolerance (author's transl)].

Authors:  C Aufrant; N Lambert-Zechovsky; Y Aujard; E Bingen; C Blum; F Beaufils; H Mathieu
Journal:  Nouv Presse Med       Date:  1981-02-26

9.  [Cefotaxime in childhood infections (author's transl)].

Authors:  J M Garnier; F Giraud
Journal:  Nouv Presse Med       Date:  1981-02-26

10.  Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects.

Authors:  S O Bergquist; S Bernander; H Dahnsjö; B Sundelöf
Journal:  Pediatr Infect Dis J       Date:  1987-05       Impact factor: 2.129

View more
  10 in total

Review 1.  State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Authors:  J E Hoppe
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

2.  Update of epidemiology, diagnosis, and treatment of pertussis.

Authors:  J E Hoppe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

Review 3.  Rational prescribing of antibacterials in ambulatory children.

Authors:  J E Hoppe
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

4.  Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance.

Authors:  J M Bartkus; B A Juni; K Ehresmann; C A Miller; G N Sanden; P K Cassiday; M Saubolle; B Lee; J Long; A R Harrison; J M Besser
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Treatment of pertussis with josamycin.

Authors:  J E Hoppe
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

6.  Treatment of pertussis with josamycin.

Authors:  D Torre
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 7.  Antimicrobial susceptibility of Bordetella pertussis (Part I).

Authors:  J E Hoppe; A Haug
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

8.  Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis.

Authors:  J E Hoppe; U Halm; H J Hagedorn; A Kraminer-Hagedorn
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

Review 9.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

10.  High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.

Authors:  Lijun Li; Jikui Deng; Xiang Ma; Kai Zhou; Qinghong Meng; Lin Yuan; Wei Shi; Qing Wang; Yue Li; Kaihu Yao
Journal:  Emerg Infect Dis       Date:  2019-12       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.